Entrada Therapeutics Inc (TRDA)
18.77
+0.72
(+3.99%)
USD |
NASDAQ |
Nov 22, 12:28
Entrada Therapeutics Gross Profit Margin (Quarterly)
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Gross Profit Margin (Quarterly) Benchmarks
| Catalyst Pharmaceuticals Inc | 85.02% |
| Vertex Pharmaceuticals Inc | 85.84% |
| Assembly Biosciences Inc | -- |
| Sarepta Therapeutics Inc | 80.37% |
| Regenxbio Inc | 48.81% |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | 17.06% |
| Return on Assets | 10.56% |
| Return on Invested Capital | 17.06% |
| Profit Margin (Quarterly) | -71.70% |
| Operating Margin (Quarterly) | -110.7% |
| Return on Net Operating Assets | 47.77% |